Jump to main content
Jump to site search

Issue 68, 2020
Previous Article Next Article

Field-based rational design of p300 histone acetyltransferase inhibitor and systematic evaluation as an anti-fibrotic agent

Author affiliations

Abstract

(E)-3-(3-(4-((3-Carbamoylbenzyl)oxy)-3-iodo-5-methoxyphenyl) acryloyl)benzamide (A6) was found to be a potent p300 inhibitor (IC50 = 870 nM) showing a similar binding mode to that of acetyl-CoA, a p300 substrate, and effective anti-fibrotic activity in both TGF-β1-stimulated lung fibroblast cells and bleomycin-induced in vivo lung fibrosis mice.

Graphical abstract: Field-based rational design of p300 histone acetyltransferase inhibitor and systematic evaluation as an anti-fibrotic agent

Back to tab navigation

Supplementary files

Article information


Submitted
18 May 2020
Accepted
13 Jul 2020
First published
15 Jul 2020

Chem. Commun., 2020,56, 9795-9798
Article type
Communication

Field-based rational design of p300 histone acetyltransferase inhibitor and systematic evaluation as an anti-fibrotic agent

S. Hwang, S. Park, J. Y. Hong, S. Y. Lee, J. Shin, Y. Na, M. H. Sohn, H. Yoon and Y. Kwon, Chem. Commun., 2020, 56, 9795
DOI: 10.1039/D0CC03553J

Social activity

Search articles by author

Spotlight

Advertisements